AzTrials
AzTrials

Pregnancy LossNCT07333391

Individualized Grief Support With Swanson Model

A study testing Assigned Interventions in people with Pregnancy Loss and Grief, run by Suleyman Demirel University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to examine the effects of individualized grief support for women experiencing pregnancy loss. The research, which will be conducted at Süleyman Demirel University, is a mixed-method design and includes both phenomenological qualitative analysis and randomized controlled quantitative trials. Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pregnancy Loss, Grief
What is being tested?
Assigned Interventions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2026to 30 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged 18 years and above,
  • Literate,
  • Able to understand and speak Turkish,
  • Desired and planned pregnancies
  • No diagnosed psychiatric illness,
  • No hearing or mental disabilit

Who cannot join

  • Women who experienced pregnancy loss after infertility treatment
  • Women who received psychological support during the process
  • Women who scored very high on the DAS scale
  • Women who withdrew from the study at any stage
  • Women who did not complete the data collection forms will be excluded from the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Fatma Pehlivan Msc, RN contact

+905068675172

fatmademirci@sdu.edu.tr

Emel Taşçı Duran Phd, RN contact

+905336434819

emelduran@sdu.edu.tr

Turkey (Türkiye)1 site
  • Suleyman Demirel University

    Isparta, Merkez, 32200

    Fatma Pehlivan Msc, RN, +905968675172, fatmademirci@sdu.edu.tr

    Emel Taşçı Duran Phd, RN, +905336434819, emelduran@sdu.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Effectiveness of Individualized Grief Support Based on the Swanson Caring Model in Women Experiencing Pregnancy Loss

This study aims to examine the effects of individualized grief support for women experiencing pregnancy loss. The research, which will be conducted at Süleyman Demirel University, is a mixed-method design and includes both phenomenological qualitative analysis and randomized controlled quantitative trials. The sample will include 48 women; those with severe depression will be excluded. Quantitative data will be analyzed using SPSS, and qualitative data will be analyzed using content analysis.

Read the detailed description

Pregnancy loss is a traumatic experience that leaves deep marks on women's lives. The grieving process that women experience during this period varies according to individual differences. The aim of this study is to examine the effects of individualized grief support for women who have experienced pregnancy loss. By addressing the emotional and psychological challenges women face after pregnancy loss, the study seeks to explore how the most appropriate support and care can be provided.

The sample of the study will consist of women who have experienced pregnancy loss at Süleyman Demirel University Research and Training Hospital, Department of Obstetrics and Gynecology. The power analysis of the study was conducted using the GPower 3.1.9.6 (Franz Faul, Universitaet Kiel, Germany) program, and the sample size was calculated as n=24+24=48. Women who obtain a very high score (14+) on the depression subscale of the Depression-Anxiety-Stress Scale will not be included in the study due to pathological findings.

This research will be conducted as a mixed-method study incorporating both qualitative and quantitative methods. In the qualitative part of the study, a phenomenological design, which is suitable for the nature of the research, will be used. The quantitative part will be conducted as a randomized controlled trial. Quantitative data are planned to be analyzed using the SPSS (Statistical Program for Social Sciences) 26.0 statistical analysis package. Qualitative data will be analyzed through content analysis using a software program commonly utilized for qualitative research.

Being tested
Assigned Interventions
Keywords
Pregnancy Loss, Grief, İndividualized care, Swanson model, Psychosocial Support

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assigned InterventionsOther

    Semi-structured interviews will be conducted with women who have experienced pregnancy loss, and their experiences and grieving processes will be examined phenomenologically. In the 3rd, 4th, and 5th interviews, based on the findings obtained from the qualitative data, grief counseling based on the Swanson care model will be provided to the women, and they will be provided with nursing care and grief support.

Study groups in NCT07333391
Study groupRoleWhat they receive
No intervention: Control GroupNo interventionWomen assigned to the control group will be administered the Personal Information Form and pretests (PGS, DAS-21) at the first interview. Nurses will instruct the women on the hospital's routine procedures. No intervention will be administered. A posttest (PGS, DAS-21) will be administered three months after the loss.
intervention groupExperimentalWomen in the intervention group will complete a Personal Information Form and baseline measures (PGS, DAS-21) during the first hospital-based interview, where they will also receive an expert-informed grief brochure. One week after pregnancy loss, a second interview involving a semi-structured, phenomenological exploration of their grief experiences will be conducted. The 3rd, 4th, and 5th interviews-held three weeks after the second interview, in the second month, and in the third month-will focus on providing grief counseling and nursing care based on the Swanson care model. In the final interview, post-test measures (PGS, DAS-21) will be administered.
Receives: Other: Assigned Interventions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Personal Information Form (Pre-Test)

    This form will be administered to women during the initial interview after they are accepted into the service.

    It was developed by researchers to determine sociodemographic characteristics such as age, marital status, pregnancy history, and educational background. Women will also undergo pre-tests (PGS and DASS-21) during the initial interview.

    Measured: At baseline (prior to intervention)

  2. Sociodemographic Characteristics Form

    This form assesses participants' sociodemographic and obstetric characteristics, including age, marital status, educational level, and pregnancy history. The form is administered by the researcher during the initial interview after participants are accepted into the service.

    Measured: Baseline (pre-intervention)

  3. Perinatal Grief Scale (PGS) Score

    The Perinatal Grief Scale (PGS) is a self-report instrument used to assess grief intensity following pregnancy loss. The scale consists of 33 items rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 33 to 165, with higher scores indicating greater levels of perinatal grief.

    Measured: Baseline (pre-intervention)

  4. Depression Anxiety Stress Scale-21 (DASS-21)

    The Depression Anxiety Stress Scale-21 (DASS-21) is a self-report instrument used to assess symptoms of depression, anxiety, and stress. The scale consists of 21 items rated on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time). The scale includes three subscales-Depression, Anxiety, and Stress-each comprising 7 items. Subscale scores are calculated by summing the relevant items and multiplying by two. Higher scores indicate greater symptom severity.

    Severity Classification:

    DASS-21 subscale scores are categorized as follows:

    Severity Level Depression Anxiety Stress Normal 0-4 0-3 0-7 Mild 5-6 4-5 8-9 Moderate 7-10 6-7 10-12 Severe 11-13 8-9 13-16 Extremely Severe ≥14 ≥10 ≥17

    Measured: Baseline (pre-intervention)

  5. Bereavement Brochure

    A bereavement brochure, prepared with the contribution of experts, will be provided to women following pregnancy loss during the initial interview. The brochure contains information about emotional reactions, coping strategies, and available support resources.

    Measured: Immediately post-intervention

  6. Semi-Structured Interview

    One week after the initial interview, semi-structured interviews will be conducted with women who have experienced pregnancy loss. In this interview, grief experiences and needs will be examined phenomenologically.

    Measured: 1 week

  7. Swanson-Based Grief Counseling (First Session)

    In the third interview, grief counseling will be provided based on findings from qualitative data. The counseling process will be structured using the Swanson Care Model.

    Measured: 3 weeks

  8. Swanson-Based Bereavement Counseling (Second Session)

    In the fourth interview, bereavement counseling will again be conducted based on the Swanson Model, tailored to the woman's ongoing needs and responses.

    Measured: 2nd month

  9. Swanson-Based Bereavement Counseling (Third Session) + Post-Test Data Collection

    During the fifth interview, bereavement counseling will continue based on the Swanson Model. At this stage, post-test data collection forms (PGS and DASS-21) will also be administered.

    Measured: 3rd month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2026
  2. Study start1 Feb 2026 (estimated)
  3. Primary completion30 Jun 2026 (estimated)
  4. Study completion30 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
This research will be conducted as a mixed methods study involving both qualitative and quantitative methods. The qualitative part of the study will utilize a phenomenological design appropriate to the nature of the study, as part of a qualitative research design. The quantitative part of the study will be conducted as a randomized controlled trial. The sample consisted of 48 individuals who experienced pregnancy loss, agreed to participate in the study voluntarily, and met the inclusion criteria.Data will be collected using a Personal Information Form containing descriptive information about the women, the Perinatal Grief Scale (33-item short version), the Depression Anxiety Stress Scale-21 (DAS-21), and a semi-structured "Interview Form" based on the Swanson Model of Care.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07333391
Sponsor's protocol ID
SDUSuleyman
Status last verified
Dec 2025
First submitted
24 Nov 2025
Last updated
12 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Assigned Interventions in people with Pregnancy Loss and Grief, run by Suleyman Demirel University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fatma Pehlivan Msc, RN (+905068675172, fatmademirci@sdu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Personal Information Form (Pre-Test) (time frame: At baseline (prior to intervention)). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in